Issue link: https://viewer.e-digitaledition.com/i/833451
AFFECTING ONLY ABOUT ONE IN 500 PEOPLE, HYPERTROPHIC CARDIOMYOPATHY žHCMŸ IS NONE THELESS THE MOST COMMON CARDIOVA SCUL AR DISE A SE WITH A GENE TIC CAUSE. BECAUSE MANY CARDIOLOGISTS SEE ONLY A HANDFUL OF CA SES THROUGHOUT THEIR CAREERS, HOWE VER, PATIENTS WITH THIS LIFE¡THRE ATENING CONDITION CAN OPTIMIZE THEIR OUTCOMES BY RECEIVING SPECIALIZED TRE ATMENT AT A HIGH¡VOLUME CENTER THAT OFFERS INTERDISCIPLINARY E XPERTISE. MEE TING THE UNIQUE NEEDS OF THOSE PATIENTS, BOTH REGIONALLY AND NATIONALLY, IS WHY WESTCHESTER MEDICAL CENTER, A MEMBER OF THE WESTCHESTER MEDICAL CENTER HE ALTH NE T WORK žWMCHE ALTHŸ, INITIATED ITS HYPERTROPHIC CARDIOMYOPATHY PROGR AM. THE PROGRAM BEGAN in fa ll 2016 and expanded with an outpatient center on Long Island in January of this year, says Julio A . Panza, MD, Chief of Cardiolog y at WMCHea lth Network. "The WMCHealth Heart and Vascular Institute was looking for ways to improve care for patients in the Hudson Va lley a n d b e y on d ," D r. Pa n z a s ay s . " We have long treated patients who have HCM, and now we have increased our capabilities to provide the full ra nge of exper tise required to be a nationa l center of excellence." Rare enough to need specialized care, yet common enough to a•ect people in communities across the country, HCM challenges providers in terms of both diag- nosis and treatment, and also with regard to marshaling institutional support to develop dedicated programs to address it. Westchester Medical Center's Hypertrophic Cardiomyopathy Program: World-class Expertise and Comprehensive Care BY JENNIFER WEBSTER Tanya Dutta, MD, Director of Echocardiography at Westchester Medical Center, and Julio Panza, MD, Chief of Cardiology at WMCHealth Network, review a patient's echocardiogram. PHOTOS © DON DEMPSEY, WHITE LIGHT/SPATINA STUDIOS 0 6 C O V E R F E A T U R E

